Nanowaste Management Policy in the Capital City, Mongolia

Abstract:

Nanotechnology is intensively developing and is mostly introduced in renewable energy, cosmetics, nanomedicine, electricity and electronics thereby increasing amount of nanowaste has been challenging issue in the world. However waste management policy in Mongolia has incomplete, nanowaste regulation has to be embedded in order to protect environment and human health. Because environmental and health impact of nanomaterial is still open field for researchers. The main objectives of this study are to introduce test results of some nanomaterials, and to evaluate waste including nanowaste management policy in Mongolia. 21 nanomaterials were tested by X-Ray Diffraction analysis, Cross Correlation Analysis and the Ames test. As a result, physical sizes of 5 nanomaterials were measured at less than 100 nm, and all samples were non-mutagenic. In conclusion, the registration of imported goods in Mongolia needs to be improved in high technology products and safety data sheet for nanomaterial is necessary due to sound disposal of hazardous waste.

• Periodical: Applied Mechanics and Materials (Volume 768)
• Pages: 29-35
• DOI: https://doi.org/10.4028/www.scientific.net/AMM.768.29
• Online since: June 2015
• Authors: Khulan Gantsolmon, Enkhjargal Choijantsan, Enkhsaikhan Danihai, Khulan Bayarsaikhan, Battuvshin Byambadorj, Erdenebayasgalan Ganjuurjav, Suvd Duvjir, Unursaikhan Surenjav*
• Keywords: Nanotechnology, Nanowaste, Waste Management Policy

References

[1] European nanotechnology landscape report.

[2] Ndeke Musee, Post nanomaterials lifespan: Nanowastes, Legislative challenges, and Proactive Approaches.

[3] Dong Ye, Michelle Nic Raghnaill, Mattia Bramini, Eugene Mahon, Christoffer Åberg, Anna Salvati and Kenneth A. Dawson, Nanoparticle accumulation and transcytosis in brain endothelial cell layers, Nanoscale, 2013, 5, 11153-11165.

DOI: 10.1039/c3nr02905k

[4] Annual statistical report (2010-2013) of Urban Development center.

[5] S2 (R1) Genotoxicity testing and Data interpretation for Pharmaceuticals Intended for human use, U.S. Department of Health and Human Services, June (2012).

[6] Information on http: /www. nanotechproject. org/cpi/about/analysis.

[7] Jeremy Allan, Sue Reed, John Bartlett and Mike Capra, Comparison of methods used to treat nanowaste from research and manufacturing facilities, Conference, 5 – 9 December 2009, Canberra, ACT in Australia.

[8] Annual statistical report of wastes (2010-2013), Urban Development center.

[9] Directive 2008/98/EC.

[10] Regulation (EC) No 1223/2009 (November 2009).

[11] Regulation (EC) No 528/2012 (May 2012).

[12] Howard Morris, Ehsan Majd, Nanotechnology Work Health and Safety Engineers Australia Seminar Brisbane, 29 April (2013).